Tenecteplase Shortens Stroke Treatment and Transfer Times
🔓 Free Teaser Neurology / Neuropharmacology Confirmatory Grade: Low
Warach SJ, Weber JM, Alhanti B, et al.
📅 Jul 13, 2026 · JAMA network open
Tenecteplase speeds up stroke thrombolysis compared to alteplase.
Prior IV thrombolysis does not dictate first-line thrombectomy technique
Neurology / Neuropharmacology Confirmatory Grade: Low
Mouyal SJ, Maïer B, Labreuche J, et al.
📅 Jul 24, 2026 · European stroke journal
Does prior thrombolysis influence thrombectomy effectiveness in stroke recovery?
Nanocarrier Delivery Systems for Epilepsy: A Preclinical Landscape Review
Neurology / Neuropharmacology Hypothesis-generating Grade: Very Low
Chauhan A, Kumar A, Awasthi A, et al.
📅 Jul 23, 2026 · The Journal of pharmacy and pharmacology
Nanocarriers show potential for improving epilepsy drug delivery.
Low-Dose Thrombolysis Plus Argatroban Signals Benefit in Ischemic Stroke
Neurology / Neuropharmacology Hypothesis-generating Grade: Very Low
Huang S, Wang X, Li D, et al.
📅 Jul 18, 2026 · Medicine
Combining tenecteplase with argatroban might enhance stroke recovery.
D-Dimer/Fibrinogen Ratio Predicts Poor Post-Thrombolysis Stroke Outcomes
Neurology / Neuropharmacology Hypothesis-generating Grade: Low
Zhang X, Fu Y, Lu J
📅 Jul 11, 2026 · Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
New biomarker DFR predicts poor stroke outcomes post-thrombolysis.
Subcutaneous Natalizumab Cuts Chair Time, Cost, Boosts Quality of Life
Neurology / Neuropharmacology Confirmatory Grade: Low
Filippi M, Grimaldi LME, Brescia Morra V, et al.
📅 Jul 10, 2026 · Journal of neurology
Subcutaneous natalizumab streamlines MS care while enhancing patient experience.
Undiluted IV Push Valproic Acid Shows Favorable Safety Across 5500 Doses
Neurology / Neuropharmacology Confirmatory Grade: Low
Rollins S, Radosevich JJ, Sammani N, et al.
📅 Jul 10, 2026 · Journal of neurology
Undiluted IV push valproic acid proves safe for rapid seizure treatment.
Subcutaneous Levodopa Infusion Cuts OFF Time in Real-World Parkinson Care
Neurology / Neuropharmacology Confirmatory Grade: Low
Ali A, Cheema WA, Shamoon M, et al.
📅 Jul 7, 2026 · Medicine
New infusion therapy eases Parkinson's motor symptoms with tolerability challenges.
IV Thrombolysis Before Thrombectomy Improves Recanalization in Extended Window
Neurology / Neuropharmacology Confirmatory Grade: Low
Nicolini E, Ciacciarelli A, Pracucci G, et al.
📅 Jul 2, 2026 · European journal of neurology
IVT pre-MT improves stroke recanalization success post-4.5 hours.
Tenecteplase Boosts Late-Window Reperfusion but Not 90-Day Function
Neurology / Neuropharmacology Hypothesis-generating Grade: Low
Cheng X, Hong L, Lin L, et al.
📅 Jan 2, 2025 · Stroke
Tenecteplase enhances late-window stroke reperfusion without added hemorrhage risk.
TIMELESS: Late-Window Tenecteplase Fails to Improve Stroke Outcomes
Neurology / Neuropharmacology Confirmatory Grade: High
Albers GW, Jumaa M, Purdon B, et al.
📅 Feb 22, 2024 · New England Journal of Medicine
Tenecteplase fails to outperform placebo in delayed stroke treatment.
Perfusion-Selected Alteplase Extends Thrombolysis Window to 9 Hours
Neurology / Neuropharmacology Hypothesis-generating Grade: Moderate
Ma H, Campbell BCV, Parsons MW, et al.
📅 May 9, 2019 · New England Journal of Medicine
Alteplase shows promise for late-presenting stroke when guided by imaging.
MRI Mismatch Extends Alteplase to Unknown-Onset Stroke
Neurology / Neuropharmacology Practice-changing Grade: Moderate
Thomalla G, Simonsen CZ, Boutitie F, et al.
📅 May 16, 2018 · New England Journal of Medicine
MRI-guided thrombolysis may benefit stroke of unknown onset.